These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8777286)

  • 41. Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections.
    Mortensen H; Kocova M; Teng LY; Keiding J; Bruckner I; Philotheou A
    Pediatr Diabetes; 2006 Feb; 7(1):4-10. PubMed ID: 16489968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HbA
    Danne T; Cariou B; Banks P; Brandle M; Brath H; Franek E; Kushner JA; Lapuerta P; McGuire DK; Peters AL; Sawhney S; Strumph P
    Diabetes Care; 2018 Sep; 41(9):1981-1990. PubMed ID: 29937431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between hypoglycemia and the type of insulin in diabetic patients treated with multiple injections: an observational study.
    Wróbel MP; Wystrychowski G; Psurek A; Szymborska-Kajanek A; Strojek K
    Pol Arch Med Wewn; 2014; 124(4):173-9. PubMed ID: 24727596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
    Guelho D; Paiva I; Batista C; Barros L; Carrilho F
    Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
    Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
    Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
    Holcombe JH; Zalani S; Arora VK; Mast CJ;
    Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.
    Chase HP; Dixon B; Pearson J; Fiallo-Scharer R; Walravens P; Klingensmith G; Rewers M; Garg SK
    J Pediatr; 2003 Dec; 143(6):737-40. PubMed ID: 14657818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus.
    Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R
    Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study.
    Blasetti A; Di Giulio C; Tocco AM; Verrotti A; Tumini S; Chiarelli F; Altobelli E
    Pediatr Diabetes; 2011 Feb; 12(1):4-10. PubMed ID: 20723102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
    Downie E; Craig ME; Hing S; Cusumano J; Chan AK; Donaghue KC
    Diabetes Care; 2011 Nov; 34(11):2368-73. PubMed ID: 22025782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparing continuous subcutaneous insulin infusion and multiple daily injections in children with Type 1 diabetes in Sweden from 2011 to 2016-A longitudinal study from the Swedish National Quality Register (SWEDIABKIDS).
    Fureman AL; Lilja M; Lind T; Särnblad S; Bladh M; Samuelsson U
    Pediatr Diabetes; 2021 Aug; 22(5):766-775. PubMed ID: 33929074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.
    Skogsberg L; Fors H; Hanas R; Chaplin JE; Lindman E; Skogsberg J
    Pediatr Diabetes; 2008 Oct; 9(5):472-9. PubMed ID: 18721168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
    de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
    Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methodology concerns in study of hypoglycemia potential under human versus animal insulin treatment.
    Stephenson J
    Diabetes Care; 1992 Aug; 15(8):1110-2. PubMed ID: 1505323
    [No Abstract]   [Full Text] [Related]  

  • 59. Adverse events in intensively treated children and adolescents with type 1 diabetes.
    Nordfeldt S; Ludvigsson J
    Acta Paediatr; 1999 Nov; 88(11):1184-93. PubMed ID: 10591418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Young children with type 1 diabetes can achieve glycemic targets without hypoglycemia: Results of a novel intensive diabetes management program.
    Phelan H; King B; Anderson D; Crock P; Lopez P; Smart C
    Pediatr Diabetes; 2018 Jun; 19(4):769-775. PubMed ID: 29504243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.